PRGO PERRIGO Co plc

PRGO financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 1585364 Exchange: NYSE SIC: 2834 (Pharmaceutical Preparations)
Showing 3 of 14 annual and 0 of 51 quarterly periods. Full history available with a free account or via API.

▼ Company Profile

Filer Category
Large accelerated filer
Entity Type
Operating
Public Float
$3.65B (Jun 2025)
Industry (SIC)
2834 Pharmaceutical Preparations
Incorporated
L2
Fiscal Year End
December (1231)
Phone
269-673-8451
EIN
000000000
Headquarters
DUBLIN 2, L2, D02 TY74
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.
Former Names: PERRIGO Co Ltd (2013–2013)

▼ Key Metrics (TTM)

As of Jun 27, 2026
Financials
Revenue
$4.14B
Net Income
$-1.73B
Total Assets
$7.61B
Total Equity
$2.52B
Total Debt
$3.29B
Free Cash Flow
$119.30M
Ratios
Gross Margin
33.3%
Operating Margin
-37.7%
Net Margin
-41.9%
Return on Equity
-69%
Return on Assets
-22.8%
Current Ratio
2.32x
Debt / Equity
1.31x
FCF / Assets
1.6%

▼ FY 2025 Summary Analysis

Annual report ending Dec 31, 2025

Overview and Growth

In fiscal 2025, PERRIGO Co plc recorded $4.25B of revenue, net loss of $1.43B, and an operating cash inflow of $238.50M. At $4.25B, the top line establishes the operating scale supporting the company’s profit and cash-flow profile. Compared with $4.37B in fiscal 2024, revenue decreased 2.8%, a top-line contraction that reduced operating scale. Diluted earnings per share were -$10.29, translating the period’s attributable earnings into the amount reported for each diluted share. At period end, total assets were $8.54B, framing the scale of the company’s operating and financing commitments. Revenue equaled 0.5x of total assets, indicating how much reported top-line activity the company produced relative to its period-end asset base.

Profitability

The first profit layer was $1.49B of gross profit, the amount available after reported direct revenue costs to absorb operating expenses. Gross margin was 35.1%, so that share of each revenue unit remained after the cost of revenue reported for the period. The company recorded an operating loss of $1.12B after the reported operating expense base. An operating margin of -26.4% reflected costs exceeding revenue-level gross profit by 26.4% of sales. After all below-operating-line items, the company recorded a net loss of $1.43B for the fiscal year. Measured against revenue, the bottom-line deficit represented 33.5% after all recognized items. Before income taxes, the company recorded a loss of $1.30B, bridging the operating result to the final net loss. The pretax loss equaled 30.5% of revenue, measuring the pre-tax deficit against sales. Income tax expense totaled $104.40M, providing the reported tax component that separates pretax and after-tax earnings. The net loss equaled 48.6% of period-end equity, showing the deficit relative to book capital. The loss-to-assets relationship was 16.7%, placing the bottom-line deficit against the company’s resource base.

Liquidity and Capital Structure

Total assets were $8.54B, supported by $5.60B of liabilities and $2.94B of shareholder equity. At period end, current assets of $2.80B compared with current liabilities of $1.01B, defining the company’s short-term resource position. At 2.76x, the current ratio shows that short-term assets were greater than short-term liabilities at period end. Reported cash and equivalents were $531.60M, separating immediately recognizable cash resources from the rest of the current-asset base. Cash and equivalents represented 52.5% of current liabilities, showing the portion of near-term obligations matched by reported cash alone. Total debt was $3.64B, establishing the amount of borrowing carried within the company’s capital structure. Debt equaled 1.24x of book equity, describing the relative scale of borrowing and shareholder capital. The debt-to-assets relationship was 42.6%, comparing borrowing with the total asset balance. Liabilities represented 65.6% of total assets, quantifying the liability-funded share of the company’s resource base. Cash and equivalents equaled 6.2% of total assets, showing the liquid cash component within the company’s broader resource base. Compared with $9.65B in fiscal 2024, the current asset base moved 11.5% and finished lower. Against $4.32B of equity in fiscal 2024, the current book-equity balance moved 32.0% and ended lower.

Cash Flow and Earnings Quality

Operating activities produced a cash inflow of $238.50M, giving the cash-flow counterpart to the accrual-based profit measures reported for the year. Capital expenditures used $93.40M, identifying the reported investment outflow deducted from operating cash flow in the free-cash-flow calculation. Capital spending absorbed 39.2% of operating cash flow, quantifying the share of cash from operations directed to investment. Free cash flow came to $145.10M, leaving a positive amount after capital expenditures. Free cash flow represented 3.4% of revenue, linking post-investment cash generation with the company’s operating scale. Measured against total assets, free cash flow represented 1.7%, showing the cash productivity of the company’s assets.
Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated .
Sources and calculation details

Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.

Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.

Annual (FY)
Quarterly 🔒
Chart 🔒
Annual financial statements for PERRIGO Co plc
Metric FY2025 📄 FY2024 📄 FY2023 📄
Income Statement
REVENUE
Revenue $4.25B $4.37B $4.66B
Cost of Revenue $2.76B $2.83B $2.98B
Gross Profit $1.49B $1.54B $1.68B
OPERATING EXPENSES
R&D Expense $95.40M $112.20M $122.50M
SG&A Expense $435.90M $468.00M $522.30M
Other Operating Expenses (derived) $2.09B $849.60M $883.70M
Operating Income $-1.12B $112.90M $151.90M
NON-OPERATING INCOME / EXPENSE
Other Income/Expense $-13.20M $900.00K $10.40M
Pretax Income $-1.30B $-80.70M $-8.30M
Income Tax $104.40M $80.00M $-3.90M
Net Income $-1.43B $-171.80M $-12.70M
PER SHARE & SUPPLEMENTAL
Diluted EPS $-10.29 $-1.25 $-0.09
Diluted Shares 138.50M 137.40M 135.30M
EBITDA $-784.70M $438.80M $511.40M
Depreciation & Amortization $337.50M $325.90M $359.50M
Balance Sheet
ASSETS
Cash & Equivalents $531.60M $558.80M $751.30M
Accounts Receivable $612.80M $642.30M $739.60M
Inventory $1.15B $1.08B $1.14B
Other Current Assets $231.40M $199.00M $201.10M
Current Assets $2.80B $2.48B $2.83B
PP&E (Net) $898.70M $917.80M $916.40M
Goodwill $2.05B $3.32B $3.53B
Intangible Assets $4.76B $4.50B $5.00B
Other Noncurrent Assets $261.80M $318.60M $335.20M
Noncurrent Assets $5.74B $7.17B $7.98B
Total Assets $8.54B $9.65B $10.81B
LIABILITIES
Accounts Payable $474.50M $495.20M $477.70M
Short-term Debt $36.60M $36.40M $440.60M
Other Current Liabilities $230.60M $238.70M $335.40M
Current Liabilities $1.01B $1.04B $1.59B
Long-term Debt $3.60B $3.58B $3.63B
Other Noncurrent Liabilities $814.30M $499.20M $559.80M
Noncurrent Liabilities $4.59B $4.28B $4.45B
Total Liabilities $5.60B $5.33B $6.04B
EQUITY
Common Stock $6.61B $6.73B $6.84B
Retained Earnings $-3.68B $-2.25B $-2.08B
Accumulated OCI $4.80M $-162.40M $10.70M
Total Equity $2.94B $4.32B $4.77B
Total Liabilities & Equity $8.54B $9.65B $10.81B
SUPPLEMENTAL
Total Debt $3.64B $3.62B $4.07B
Shares Outstanding 137.60M 136.50M 135.50M
Check: A − (L + E + NCI) - - -
Cash Flow Statement
Cash from Operations $238.50M $362.90M $405.50M
Capital Expenditures $93.40M $118.30M $101.70M
Cash from Investing $-75.40M $78.80M $-77.50M
Cash from Financing $-220.50M $-611.00M $-187.20M
Free Cash Flow $145.10M $244.60M $303.80M
Beginning Cash (CFS) $558.80M $751.30M -
Net Change in Cash $-57.40M $-169.30M -
Effect of FX on Cash $32.50M $-23.20M $9.80M
Calculated Ending Cash $533.90M $558.80M -
Cash per BS $531.60M $558.80M $751.30M
Cash scope difference (CFS − BS) - - -
Cash per CFS $531.60M ! $558.80M $751.30M

Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.

Create Free Account Log In
🔒

Quarterly data and charts require a free account

Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.

▼ Frequently Asked Questions

What is PERRIGO Co plc's annual revenue?

PERRIGO Co plc reported $4.14B in revenue for trailing twelve months (ending June 2026). Revenue figures are sourced from the company's annual SEC EDGAR filing.

Is PERRIGO Co plc profitable?

No. PERRIGO Co plc reported $-1.73B in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.

What is PERRIGO Co plc's debt level?

PERRIGO Co plc carries $3.29B in total debt as of trailing twelve months. Total shareholders' equity stands at $2.52B.

Does PERRIGO Co plc generate free cash flow?

Yes. Free cash flow was $119.30M for trailing twelve months. Operating cash flow was $196.10M.